Top companies in In Vitro Diagnostics (IVD) by Cyborg Score (2026)

The 6 highest-scored In Vitro Diagnostics (IVD) companies in the AskCyborg corpus, ranked by Cyborg Score — a 1–10 rating from a bull-vs-bear AI analyst debate across 11 dimensions. Leading the table: Eurobio Scientific (7/10), Gentian Diagnostics ASA (7/10), bioMérieux S.A. (7/10).

#CompanyCyborg ScoreThe verdictOwnershipPeers
1Eurobio Scientific7/10Growth-stage diagnostics specialist with strong organic momentum, proprietary products, and strategic institutional backing, though facing mPublic
2Gentian Diagnostics ASA7/10Niche diagnostics player with strong organic growth, improving margins, and strategic partnerships, positioned to capture market share in hiPublic
3bioMérieux S.A.7/10Specialized diagnostics leader with niche market dominance and diversified revenue streams, trading at premium valuations reflecting growth Public
4BioPorto A/S5/10Niche diagnostics player with strong product validation but limited scale—recovery depends on FDA approvals and commercial penetration accelPublic
5EKF Diagnostics Holdings plc5/10Diversified diagnostics player with global distribution but challenged by modest margins and valuation dynamics in competitive IVD market.Public
6OraSure Technologies, Inc.4/10Turnaround story with near-term product catalysts but facing significant execution risk amid challenging market conditions and profitabilityPublic

See also In Vitro Diagnostics (IVD) industry research and the full industry ratings index.

Cyborg Scores (1–10) are synthesized by AskCyborg’s multi-agent analyst-debate framework across 11 dimensions, recalibrated weekly. How the score works · Methodology.